Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Charpentier CRISPR patent gets good news from Japan
Genetics
Novelty and inventive step of patent owned by ERS Genomics and Emmanuelle Charpentier withstand challenge at Japan Patent Office | Invalidity proceedings also rejected by JPO in 2021.   14 December 2023
Acadia defends Parkinson’s drug patent against obviousness-type double patenting attack
Big Pharma
Court rules that patent must be later-filed to be available as OTDP reference | MSN had submitted ANDA for generic version of Parkinson’s treatment Nuplazid.   14 December 2023
Biden takes aim at big pharma in controversial plan
Big Pharma
US government takes on price gouging in latest raft of proposals | IP attorney says the “unfortunate decision” will deter future public-private collaboration | Move prompts concern over government's future use of march-in rights.   12 December 2023
Big Pharma
Hearing is latest in dispute between the biotech research firms | Multi-jurisdictional case concerns patents relating to the in-situ detection of analytes.   12 December 2023
Big Pharma
Case dismissed with settlement between Novartis and Daiichi Sankyo unit | Melanoma therapy at centre of feud after Novartis faced infringement claims over Tafinlar.   7 December 2023
Big Pharma
The UK pharmaceutical company filed three lawsuits against Sun Pharma | Sun’s abbreviated new drug application for generic versions of diabetes medications sparks fightback.   7 December 2023
Biotechnology
Emcure fends off COVID-19 trade secrets suit in Washington | A US biotech had inked a short-lived deal with Indian generic pharma company’s subsidiary.   5 December 2023
Big Pharma
USPTO director remanded case back to PTAB after it denied post-grant review of Spruce patents | Judges determined likelihood of claims being unpatentable due to prior art and lack of written description.   5 December 2023
Americas
Two new partners, who have been appointed at the Canadian law firm’s Toronto office, bring ‘extensive’ track records of success in complex patent litigation.   5 December 2023
Generics
Final award follows and incorporates the August 2022 decision by the arbitrator denying all claims levied at the Japanese company | Dispute involves antibody drug conjugate technology.   30 November 2023